Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Uni-Bio Science Group's yield on cost for the quarter that ended in Dec. 2025 was 0.00.
The historical rank and industry rank for Uni-Bio Science Group's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Uni-Bio Science Group's highest Yield on Cost was 5.45. The lowest was 2.38. And the median was 3.08.
UNBSF's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.59 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Uni-Bio Science Group (OTCPK:UNBSF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Uni-Bio Science Group 5-Year Yield-on-Cost % Related Terms
UNBSF vs VRTX, REGN, RVMD: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Uni-Bio Science Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Uni-Bio Science Group 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Uni-Bio Science Group's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Uni-Bio Science Group's 5-Year Yield-on-Cost % falls into.
Uni-Bio Science Group 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Uni-Bio Science Group (UNBSF) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 20, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Uni-Bio Science Group and its competitors. Over the past decade, Uni-Bio Science Group's 5-Year Yield-on-Cost % has ranged from 2.38 to 5.45. According to the industry distribution chart, Uni-Bio Science Group ranks #26 out of 149 companies in the Biotechnology industry, placing it in the top 17.4%.
Is Uni-Bio Science Group's 5-Year Yield-on-Cost % too high?
Uni-Bio Science Group's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 2.38 to a high of 5.45. Based on the distribution chart, Uni-Bio Science Group ranks #26 out of 149 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Uni-Bio Science Group has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Uni-Bio Science Group's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Uni-Bio Science Group ranks #26 out of 149 companies for 5-Year Yield-on-Cost %. This places Uni-Bio Science Group in the top 17% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 1.59. Historically, Uni-Bio Science Group's own 5-Year Yield-on-Cost % has ranged from 2.38 to 5.45 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.59, based on 149 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Uni-Bio Science Group and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Uni-Bio Science Group's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uni-Bio Science Group stock overvalued right now?
Uni-Bio Science Group (UNBSF) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 60% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Uni-Bio Science Group's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Uni-Bio Science Group (UNBSF), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Uni-Bio Science Group (UNBSF) Overvalued in 2026?
Based on GuruFocus' analysis, Uni-Bio Science Group stock appears to be undervalued.
The current stock price of $0.00 is trading 60% below its estimated GF Value™ of $0.01.
Key valuation signals for UNBSF:
5-Year Yield-on-Cost %: 0.00
GF Value™: $0.01 vs. price of $0.00 (60% below fair value)
No single metric tells the full story. See the UNBSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.
58GF Score
Get the complete analysis for UNBSF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UNBSF has been successfully added to your 
